The ATLAS [10] and HEAAL [25] trials showed that higher doses of ACE inhibitors or ARBs significantly reduced HF hospitalizations compared with lower doses, and the HF‐ACTION study [26] found that de‐escalation of ACE inhibitors or β‐blockers was associated with increased mortality. Here, ACE is linked to hydrops fetalis.